Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis

Once considered potential liabilities, the modern era witnesses a renaissance of interest in covalent inhibitors in drug discovery. The available toolbox of electrophilic warheads is limited by constraints on tuning reactivity and selectivity. Following our work on a class of ferroptotic agents term...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry Vol. 65; no. 17; pp. 11788 - 11817
Main Authors: Karaj, Endri, Sindi, Shaimaa H., Kuganesan, Nishanth, Perera, Lalith, Taylor, William, Tillekeratne, L. M. Viranga
Format: Journal Article
Language:English
Published: United States American Chemical Society 08-09-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Once considered potential liabilities, the modern era witnesses a renaissance of interest in covalent inhibitors in drug discovery. The available toolbox of electrophilic warheads is limited by constraints on tuning reactivity and selectivity. Following our work on a class of ferroptotic agents termed CETZOLEs, we discovered new tunable heterocyclic electrophiles which are capable of inducing ferroptosis. The biological evaluation demonstrated that thiazoles with an alkyne electrophile at the 2-position selectively induce ferroptosis with high potency. Density functional theory calculations and NMR kinetic studies demonstrated the ability of our heterocycles to undergo thiol addition, an apparent prerequisite for cytotoxicity. Chemoproteomic analysis indicated several potential targets, the most prominent among them being GPX4 protein. These results were further validated by western blot analysis and the cellular thermal shift assay. Incorporation of these heterocycles into appropriate pharmacophores generated highly cytotoxic agents such as the analogue BCP-T.A, with low nM IC50 values in ferroptosis-sensitive cell lines.
ISSN:0022-2623
1520-4804
DOI:10.1021/acs.jmedchem.2c00909